| BRAND NAME | APPLICATION | SPONSOR | STATUS |
|---|---|---|---|
| NEUPOGEN | BLA103353 | AMGEN | Prescription |
| PRODUCT NAME | HOLDER | STATUS | DATE | INDICATION |
|---|---|---|---|---|
| Nivestim | Pfizer Europe MA EEIG | Authorised | 07/06/2010 | Hematopoietic Stem Cell Transplantation;Cancer |
| Accofil | Accord Healthcare S.L.U. | Authorised | 17/09/2014 | — |
| Zefylti | CuraTeQ Biologics s.r.o | Authorised | 12/02/2025 | Neutropenia;Hematopoietic Stem Cell Transplantation;Cancer |
| Grastofil | Accord Healthcare S.L.U. | Withdrawn | 18/10/2013 | — |
| Filgrastim Hexal | Hexal AG | Authorised | 06/02/2009 | Hematopoietic Stem Cell Transplantation;Cancer |
| Zarzio | Sandoz GmbH | Authorised | 06/02/2009 | Hematopoietic Stem Cell Transplantation;Cancer |
| Tevagrastim | Teva GmbH | Authorised | 15/09/2008 | Hematopoietic Stem Cell Transplantation;Cancer |
| Ratiograstim | Ratiopharm GmbH | Authorised | 15/09/2008 | Hematopoietic Stem Cell Transplantation;Cancer |
| Zefylti | CuraTeQ Biologics s.r.o | Application withdrawn | — | |
| Biograstim | AbZ-Pharma GmbH | Withdrawn | 15/09/2008 | Hematopoietic Stem Cell Transplantation;Cancer |